An AI model called EVE-Vax uses evolutionary, biological and structural information about a virus to predict and design ...

"We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines," said first author Noor Youssef, a scientific lead for the Predictive Modeling for ...

COVID-19 is still around and can pose a risk of serious illness to vulnerable people. What are the symptoms in 2025? And how ...

The COVID incubation period can range from two to 14 days. On average, it takes 3-5 days to start developing symptoms after a ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Researchers have created an AI tool called EVE-Vax that can predict and design viral proteins likely to emerge in the future.For ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future pandemic preparedness.

Researchers examined the incidence of long COVID among adult and pediatric patients using data captured from 3 large cohorts between 2020 and 2024.

GEO-CM04S1 Demonstrates Robust COVID-19 and Mpox Immunogenicity in Immunocompromised Patients and Healthy Adults ATLANTA, GA - May 8, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical ...

"It's highly unlikely that COVID-19 patients seeking care in the US at this time are infected with a variant other than Omicron," said Cavazzoni. Avoiding use of the Lilly and Regeneron antibodies ...